(Q33991800)

30 July 2017

1 reference

title

Phenolic antioxidants: a rationale for design and evaluation of novel antioxidant drug for atherosclerosis (English)

1 reference

30 July 2017

1 reference

Noguchi N

1

1 reference

PubMed ID

10927179

30 July 2017

Niki E

series ordinal

2

1 reference

30 July 2017

1 May 2000

1 reference

Free Radical Biology and Medicine

30 July 2017

1 reference

30 July 2017

28

1 reference

30 July 2017

10

1 reference

30 July 2017

1538-1546

1 reference

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Presence of hypochlorite-modified proteins in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Vitamin E consumption and the risk of coronary disease in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Vitamin E consumption and the risk of coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Studies on the mechanism of action of probucol

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Antiatherogenic effects of the antioxidant BO-653 in three different animal models.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Interaction among vitamin C, vitamin E, and beta-carotene

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Antioxidant activities of probucol against lipid peroxidations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Inhibition of oxidation of low density lipoprotein by vitamin E and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Dynamics of lipid peroxidation and its inhibition by antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

The peroxidizing effect of α-tocopherol on autoxidation of methyl linoleate in bulk phase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

2,3-Dihydro-5-hydroxy-2,2-dipentyl-4,6-di-tert-butylbenzofuran: design and evaluation as a novel radical-scavenging antioxidant against lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Inhibition of oxidation of low-density lipoprotein by a novel antioxidant, BO-653, prepared by theoretical design

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Antioxidant BO-653 and human macrophage-mediated LDL oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Antioxidant activity and serum levels of probucol and probucal metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Vitamin E and vascular homeostasis: implications for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

d-alpha-Tocopherol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Vitamin E protects against polymorphonuclear leukocyte-dependent adhesion to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Is lipid peroxidation relevant to atherogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Oxidation of lipids in low density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Protein-bound acrolein: potential markers for oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Oxidized phospholipids as a new landmark in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

Oxysterols and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900256-2

7 January 2021

10.1016/S0891-5849(00)00256-2

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10927179